Industry news

Pages: < 1 2 3 4 5 6 >

18/12/2013: Philips Unveils First Digital Detector PET/CT System at RSNA 2013
Philips unveiled the Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system at the Radiological Society of North America Annual Meeting (RSNA 2013) in Chicago.
16/12/2013: Treatment Plans for Brain Metastases More Accurately Determined with Aid of Molecular Imaging Tracer
Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases.
16/12/2013: Ru-82 3D PET/CT MPI training leads to 94% inter-reader agreement
The Rubidium-ARMI (alternative radiopharmaceutical for myocardial imaging) multicenter trial has established a bar for assessing myocardial perfusion imaging (MPI).
27/11/2013: NNSA Awards Funding to Accelerate Non-HEU-Based Production of Molybdenum-99 in the United States
The Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) announced the award of a cooperative agreement that accelerates the dual objectives of eliminating the use of proliferation-sensitive highly enriched uranium (HEU) in the production of medical isotopes and establishing reliable domestic supplies of Molybdenum-99 (Mo-99) to meet U.S. patient needs.
27/11/2013: NNSA, Rosatom, UK Ministry of Defence Hold Trilateral Nuclear Security Best Practices Workshop
Representatives from the U.S. National Nuclear Security Administration (NNSA), U.K.’s Ministry of Defence (MoD), and Russia’s State Atomic Energy Corporation “Rosatom” met Nov. 5-6 in Lisbon, Portugal, for the Eighth Nuclear Security Best Practices Exchange.
27/11/2013: Research and Markets Estimates Global Market for Medical Imaging Devices at $30.2 billion
27/11/2013: PET with 62Cu-ATSM, 62Cu-PTSM identifies hypoxia, perfusion in pulmonary lesions
Evaluating lung masses by visualizing hypoxia and perfusion is feasible with copper-diacetyl-bis (62Cu-ATSM) and copper-pyruvaldehyde-bis (62Cu-PTSM) PET scans.
19/11/2013: Mallinckrodt Releases Letter Updating the Mo-99 Supply Outlook
Mallinckrodt released a customer letter which provides an update to the current outlook on Mo-99 availability for the remainder of 2013.
19/11/2013: Gallium-68 DOTATOC Receives FDA Orphan Drug Designation for Neuroendocrine Tumor Management
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce that the radiopharmaceutical Gallium-68 (DOTA0-Phel-Tyr3) octreotide (Ga-68 DOTATOC) has been designated as an orphan drug by the U.S.
19/11/2013: Radioisotope ID’s high-risk, ruptured coronary plaques
PET-CT using the radioisotope 18F-sodium fluoride (18F-NaF) identified high-risk and ruptured plaques in patients with stable and unstable coronary heart disease.

Pages: < 1 2 3 4 5 6 >